Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation

Transplantation

Volumn 71, Issue 7, 2001, Pages 892-895

  Cauble, Michele S ^a   Gilroy, Richard ^a   Sorrell, Michael F ^a   Mailliard, Mark E ^a   Sudan, Debra L ^a   Anderson, Joseph C ^a   Wisecarver, James L ^a   Balakrishnan, Sajeev ^a   Larsen, Jennifer L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INSULIN;

ADULT; ARTICLE; CASE REPORT; DIABETES CONTROL; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN TREATMENT; LIPOATROPHIC DIABETES MELLITUS; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 0035870558     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200104150-00012     Document Type: Article

References (10)

1. The syndromes of total lipodystrophy and partial lipodystrophy
2. Generalized lipodystrophy, congenital and acquired (lipoatropathy)
3. Lipodystrophy associated with an HIV-protease inhibitor
4. Lipoatrophic diabetes: Genetic exclusion of the insulin receptor gene
5. Nonalcoholic steatohepatitis
6. Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance
7. The natural history of nonalcoholic fatty liver: A follow-up study
8. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient
9. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation
10. Recurrence of nonalcoholic steatohepatitis following liver transplantation